Both are inflammatory bowel diseases (IBD), but ulcerative colitis only affects the inner lining of the large intestine, while Crohn’s disease can affect any part of the digestive tract.
Clinical trials for ulcerative colitis offer hope for individuals to achieve a normal quality of life.
Ulcerative colitis is a prevalent inflammatory bowel disease (IBD) that triggers inflammation in the colon and rectum, leading to symptoms like diarrhea, abdominal discomfort, and occasional rectal bleeding. Research says roughly 907,000 people in the US have ulcerative colitis, with an annual incidence rate of 12.2 cases per 100,000 individuals. The primary method for diagnosing UC is through colonoscopy observations.
Ulcerative colitis can result in localized complications within the intestines or systemic complications affecting the entire body. Localized inflammation may lead to issues like ulcers, while systemic inflammation can cause extra-intestinal complications such as joint pain, skin problems, and eye inflammation.
Hightower is working towards a future free from ulcerative colitis. Our approach integrates the latest research and innovative clinical trials to unlock better outcomes and better the life of individuals.
*Participation in the Clinical Trial is completely free of cost and is your choice.
*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.
Study Name | Protocol Number | Sponsor |
---|---|---|
Ulcerative Colitis | Takeda | |
Gilead | ||
Ferring | ||
Pfizer | ||
Takeda |
Ulcerative colitis is a form of inflammatory bowel disease and presents a significant health challenge affecting millions worldwide. Its incidence has steadily risen over recent years. It is usually caused by environmental or physiological factors.
Furthermore, as ulcerative colitis is associated with an increased risk of colorectal cancer, their research may also have implications for cancer prevention.
Hightower Clinical Research is actively tackling this pressing medical issue by leading investigations into the efficacy and safety of innovative drugs tailored specifically for ulcerative colitis treatment.
*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.
*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.
If you decide to participate in the Ulcerative Colitis Clinical Trials in Oklahoma City, OK, by filling out the form above, someone from the study team will contact you to determine your eligibility. The team will go over the study details with you to see if you meet the eligibility criteria for Ulcerative Colitis Research.
If you meet the eligibility criteria, you’ll receive an invitation for screening at the study site, located within a 50-mile radius of your current location. The study doctors will discuss the duration and potential impact of participating in clinical trials. Feel free to ask any questions you have. Once everything is thoroughly explained, participants will be asked to sign an Informed Consent Form, emphasizing our commitment to transparency and open communication between participants and investigators.
*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.*
18 Years to 75 Years Old
Male & Female
Ulcerative Colitis
Recruiting
Crohn’s disease is a chronic inflammatory condition affecting the digestive tract, leading to symptoms like persistent diarrhea, abdominal pain, rectal bleeding, fatigue, and weight loss.
These symptoms can vary in severity and may come and go in periods of flare-ups and remission. Other common symptoms include
Managing Crohn’s disease requires a multifaceted approach involving medications, dietary changes, lifestyle adjustments, and regular monitoring by healthcare providers.
Hightower is dedicated to advancing research and treatments for Crohn’s disease, emphasizing improved outcomes and support for patients and their families. We aim to enhance quality of life and promote better health outcomes for those affected by this condition.
Both are inflammatory bowel diseases (IBD), but ulcerative colitis only affects the inner lining of the large intestine, while Crohn’s disease can affect any part of the digestive tract.
Treatment options vary but may include medication, dietary changes, and in some cases, surgery. Hightower offers a personalized approach to find the best plan for you.
Hightower offers clinical trials for ulcerative colitis. To learn more and see if you qualify, visit our website or contact us today via the form!